Evidence map›Paper›PMID 26322111›Full record

ArticleHepatitis monthly2015

HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes.

Yizhong Wang, Jieliang Li, Xu Wang, Yu Zhou, Ting Zhang, Wenzhe Ho

Open access · hybridAbstract read
In one paragraph

Article in Hepatitis monthly, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Liver Macrophages in the Pathogenesis of Viral Hepatitis.Current issues in molecular biology · 2026
    Review
  2. Macrophages in oncoviral infections: from immune regulators to therapeutic targets.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Article
  8. Nuclear import sequence identification in hOAS3 protein.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yizhong WangDepartment of Infectious Diseases, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Jieliang LiDepartment of Pathology and Laboratory Medicine, School of Medicine, Temple University, Philadelphia, USA.
Xu WangDepartment of Pathology and Laboratory Medicine, School of Medicine, Temple University, Philadelphia, USA.
Yu ZhouDepartment of Pathology and Laboratory Medicine, School of Medicine, Temple University, Philadelphia, USA.
Ting ZhangDepartment of Infectious Diseases, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Wenzhe HoDepartment of Pathology and Laboratory Medicine, School of Medicine, Temple University, Philadelphia, USA.
Temple University · USShanghai Jiao Tong University · CN

Funding

Opioids, HIV/HCV and Host Cell Innate ImmunityR01DA022177 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2007 to 2017
$2.9M
Opioids, LPS and HIVR01DA027550 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2010 to 2014
$1.4M
Opioid, Astroglial TLR3/RIG-I Signaling and HIVR21DA036163 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2013 to 2014
$426k
Methamphetamine, Brain Endothelial TLR3 Signaling and HIVR03DA036413 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI LI, JIELIANG · 2014 to 2015
$155k
NIDA NIH HHS R01 DA022177NIDA NIH HHS R01 DA027550NIDA NIH HHS R03 DA036413NIDA NIH HHS R21 DA036163
6 · The paper itself

Abstract

backgroundMacrophages play critical roles in innate immune response in the liver. Whether macrophages participate in liver innate immunity against HCV replication is poorly understood.

objectivesThe aim of this study was to investigate the role of macrophages in liver innate immunity against HCV replication. MATERIALS AND

methodsFreshly isolated monocytes were purified from peripheral blood of healthy adult donors. Macrophages refer to 7-day-cultured monocytes in vitro. A hepatoma cell line (Huh7) was infected with HCV JFH-1 to generate in vitro HCV infectious system. RT-PCR was used to determine HCV RNA and mRNA levels of genes expression. ELISA was used to measure the protein level of interferon-α (IFN-α) and western blot was used to determine protein expression level of Toll-like receptor 3 (TLR3).

resultsHCV dsRNA induced the expression of type I IFN (IFN-α/β) in monocyte-derived macrophages. HCV dsRNA also induced the expression of TLR3 and IFN regulatory factor-7 (IRF-7), the key regulators of the IFN signaling pathway. When HCV JFH-1-infected Huh7 cells were co-cultured with macrophages activated with HCV dsRNA or incubated in media conditioned with supernatant (SN) from HCV dsRNA-activated macrophages, HCV replication was significantly suppressed. This macrophage SN action on HCV inhibition was mediated through type I IFN, which was evidenced by the observation that antibody to type I IFN receptor could neutralize the macrophages-mediated anti-HCV effect. The role of type I IFN in macrophages-mediated anti-HCV activity is further supported by the observation that HCV dsRNA-activated macrophages SN treatment induced the expression of several IFN-stimulated genes (ISGs), ISG15, ISG56, OAS-1, OAS-2, MxA and Viperin in HCV-infected Huh7 cells.

conclusionsMacrophages may play an important role in liver innate immunity against HCV replication through a type I IFN-dependent mechanism.

Indexed as

Hepatitis C VirusInterferonMacrophagesToll-Like Receptor 3

Identifiers

PMID26322111
PMCPMC4546812
OpenAlexW1771574019

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.